One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
Lurbinectedin with atezolizumab maintenance therapy in extensive-stage small-cell lung cancer
First-line immunotherapy combination in squamous cell anal carcinoma: hope in a neglected disease
The Pandemic Agreement is a milestone: now it is time for action in national capitals
The Gavi Leap: radical transformation for a new global health architecture
The potential impact of the Trump administration policies on health research in the USA
Sudan's tuberculosis response needs global support amid conflict
Digital acceptance and commitment therapy for fibromyalgia – Authors' reply
Beyond deficit models in early childhood development science – Authors' reply
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial
Surgery versus corticosteroid injection for carpal tunnel syndrome (DISTRICTS): an open-label, multicentre, randomised controlled trial
